Kelly O'Neill (Kelly Young) retweeted
So important to have coordinated multi specialty care for patients with #takayasu Arteritis #vasculitis @MayoClinic #Vascular center
Great case by Dr Manju Kalra in collaboration with rheumatology and CV surgery due to ascending aortic aneurysm. Complex cases need multidisciplinary care @MayoClinic @MdWarrington @MayoClinicCVS
Kelly O'Neill (Kelly Young) retweeted
Analysis of 17,000 adults taking Vit D and/or omega-3, showing no impact on cancer and CVD but reduced incidence of autoimmune disease by 25% to 30% in older adults vs those who received neither. Supplements without adverse events. medpagetoday.com/meetingcove…
Kelly O'Neill (Kelly Young) retweeted
Before I walk into the exam room, I try to make a mental intention to ask #patients with #rheum diseases about their #goals.
Research by @rawarrior & @RheumPF in collaboration w/ #mayoclinicrheumatology suggests we do not do this enough.
#MindfulMondays
onlinelibrary.wiley.com/doi/…
Kelly O'Neill (Kelly Young) retweeted
Concerning data in our #ACR21 poster no. 1167
#RA pts whose main #goal is less #pain also report:
- not having a #treatment plan
- longer duration before Rx
- more DMARDs tried
- lower patient satisfaction
Unmet #healthcare needs for #RA persistent pain
@rawarrior @RheumPF
Kelly O'Neill (Kelly Young) retweeted
We need practical approaches for #goal based shared decision making for patients with #rheum diseases.
Here’s a big shout out to @JenBartonMD and @glynelwyn for their strong work in this field.
@rawarrior @RheumPF @MyasoedovaElena @CrowsonCindy
#sdm #goalsetting #ACR21
Kelly O'Neill (Kelly Young) retweeted
This (@rheum_covid) was formed on Twitter (!) from a now-legendary tweet by @LCalabreseDO in early 3/2020. The physician registry is administered jointly by UCSF and EULAR.
Physicians can voluntarily enter cases of rheumatic diseases who had COVID-19
1st partial control in 16 yrs frequently in jeopardy due to disorganized #rheum office sending scripts late. #30dayscriptssuck Too many people with rheumatoid disease (PRD) suffering unnecessarily still by improper management of the tools we do have.
We must not let control of disease be lost, even in times of drug shortages. Thank you @Garethiacobucci @bmj_latest for helping to bring this urgent topic forwards in the pursuit of protecting patients, everywhere at this time.
Unfortunately, calling this disease by "the A word" perpetuates the myths that delay treatment---for a disease that's successfully treatable only if it's caught early. #rheumdisease doesn't start or end in the joints #ACR21 #rheum
"Until I was diagnosed, I thought that ‘arthritis’ was just something that old people get.”
Until you or someone close to you is diagnosed with rheumatoid arthritis (RA), unfortunately, this is most people’s perception of the disease.
To find out more nras.org.uk/resource/rheumat…
Kelly O'Neill (Kelly Young) retweeted
Does treatment with #JAKinhibitors increase risk of venous #thromboembolism in RA patients?
👉rdcu.be/cynRz
#RheumatoidArthritis #RheumTwitter
Kelly O'Neill (Kelly Young) retweeted
It is always an exciting day for Team ACR when the abstracts are published! Thank you to the ~2,000+ presenters for sharing your research. We are honored to showcase your work at #ACR21.
#ACR21 abstracts now online! NOTE: To coincide with virtual meeting early access, information that goes beyond that contained in the abstract is under embargo until Nov. 1 at 10 AM ET. Browse → acr.tw/30RaIzl
Kelly O'Neill (Kelly Young) retweeted
Today I had back to back experiences in which patients for long term follow up had ongoing symptoms, explainable if others took time to mull it over rather than fit into a 15 minute visit.
Active listening is so important, even if you can't do something to 'solve' it #survonc
Kelly O'Neill (Kelly Young) retweeted
Patients with #rheum diseases, what do you think about the #CovidVaccine? Share your experiences and opinions in this survey. Many translations available.@ArLARheumatolog @arlarrheumatolog
@acaeaoficial @lupusalua @FADEPOF @LupusCordoba
@AMAR_GRUPO @LupusAIJ_AC @PanlarJ @SCReuma
#rheum patients: what are your thoughts about COVID-19 vaccines? Whether you have or haven't been vaccinated-we want to hear from you! rheum-covid.org/vaccine-surv… In English, Spanish, Hebrew, French, Italian, Russian, Punjabi, Mandarin, & Arabic and more. #PAGC19
@IAPOvoice
Kelly O'Neill (Kelly Young) retweeted
Just posted: Plain Language Summary of Medications Impacting Response to COVID-19 Vaccines rheum-covid.org/covaripad-su…
reminds me of what a scholarship participant Erin said in #RheumDay Zoom: not everyday is a yes day #rheum
Usually, it takes me most of the days realize that I feel too crappy to get anything done. My goal is to learn to recognize days like that so I don't waste precious energy on trying and instead, just heal so the next day is better.
#rheum
Kelly O'Neill (Kelly Young) retweeted
FINCH1 RCT of filgotinib (JAKi) in RA vs. PLBO and ADA, @ARD_BMJ
Better ACR20 wk12 (77% vs 50% PLBO, NNT~4); small infxn rsk and no MACE signal
Held up @US_FDA d/t
sperm count concerns; may come to market next year?
See pics for other JAKi; network meta analysis anyone?
Kelly O'Neill (Kelly Young) retweeted
Shots fired! Strong letter & rebuttals in @NEJM re:UPA vs ABA RCT
I covered this on the podcast & agree w/both sides:
1. DAS28-CRP was a silly primary outcome
2. CDAI also looked better for UPA
Moral of the story: don’t play shenanigans with outcome measures!
Kelly O'Neill (Kelly Young) retweeted
Not all researchers have the opportunity to receive expert advice on their #clinical research projects from experienced researchers. This led us to set up the EULAR #ConsultationService.
Researchers can request the free service here:
eular.org/vrc_eular_consulta…
#rheum #rheumatic
Kelly O'Neill (Kelly Young) retweeted
Latest data tables from The COVID-19 Global Rheumatology Alliance Provider-Entered registry: rheum-covid.org/updates/comb…
